CorMedix Inc. (CRMD)Healthcare | Biotechnology | Parsippany, United States | NasdaqGM
7.53 USD
+0.14
(1.894%)
⇧
(Oct. 15, 2026, 10:25 a.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 3:36 a.m. EDT
The fundamental picture is a tale of two realities: a business with exceptional current profitability and a stock that has suffered a brutal multi-year decline. The company boasts a 55% return on equity, 90% gross margins, and a massive 156% revenue surge, proving the core product is working. However, the market has punished the stock relentlessly, dragging the price down 77% over the last decade and leaving it trading at a fraction of its historical value. While the valuation metrics look cheap, the lack of a consistent upward price trend over the last nine years signals deep structural doubts about future scalability or regulatory hurdles that the market hasn't priced out yet. Short-term, the stock is stuck in a tug-of-war. The recent 11% drop and the heavy put volume suggest fear of further deterioration, yet the strong call interest at higher strikes hints at a potential catalyst-driven bounce. With no dividend to provide income and a low reliability score from statistical models, the path forward is unclear. Investors are waiting for the next piece of data to confirm whether this is a temporary dislocation or a permanent value trap. Until the price history shows a sustained recovery, the risk remains elevated. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.073761 |
| AutoARIMA | 0.073764 |
| AutoTheta | 0.082552 |
| MSTL | 0.096597 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 1.94 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.485 |
| Excess Kurtosis | -0.87 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 31.997 |
| Revenue per Share | 5.91 |
| Market Cap | 586,920,768 |
| Trailing P/E | 3.67 |
| Forward P/E | 21.51 |
| Beta | 1.41 |
| Profit Margins | 40.49% |
| Website | https://cormedix.com |
As of Oct. 10, 2026, 3:36 a.m. EDT: Speculators are positioning for significant volatility rather than a clear directional move. Call Open Interest is heavily skewed toward out-of-the-money strikes ($10, $12, $13), suggesting bets on a sharp rally or biotech catalyst event. Conversely, Put Open Interest is massive at lower strikes ($3, $7, $8), indicating a strong hedge against downside or a 'crash' scenario. This heavy put weight at near-the-money levels creates a high implied cost for buyers, while the lack of deep ITM call volume suggests skepticism about a sustained run above current levels without a major catalyst.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.26686507 |
| Address1 | 389 Interpace Pkwy |
| Address2 | Suite 450 |
| All Time High | 52.0 |
| All Time Low | 0.75 |
| Ask | 9.71 |
| Ask Size | 2 |
| Audit Risk | 9 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 1,135,490 |
| Average Daily Volume3 Month | 1,098,100 |
| Average Volume | 1,098,100 |
| Average Volume10Days | 1,135,490 |
| Beta | 1.406 |
| Bid | 5.35 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 5.933 |
| City | Parsippany |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.53 |
| Current Ratio | 2.564 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 7.61 |
| Day Low | 7.49 |
| Debt To Equity | 31.997 |
| Display Name | CorMedix |
| Dividend Date | 1,553,558,400 |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,624,200 |
| Earnings Call Timestamp Start | 1,786,624,200 |
| Earnings Growth | 0.067 |
| Earnings Quarterly Growth | 0.311 |
| Earnings Timestamp | 1,786,624,200 |
| Earnings Timestamp End | 1,794,832,200 |
| Earnings Timestamp Start | 1,794,832,200 |
| Ebitda | 262,548,000 |
| Ebitda Margins | 0.56798 |
| Enterprise To Ebitda | 1.778 |
| Enterprise To Revenue | 1.01 |
| Enterprise Value | 466,771,552 |
| Eps Forward | 0.35 |
| Eps Trailing Twelve Months | 2.05 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 7.8316 |
| Fifty Day Average Change | -0.30159998 |
| Fifty Day Average Change Percent | -0.038510647 |
| Fifty Two Week Change Percent | -26.686508 |
| Fifty Two Week High | 13.02 |
| Fifty Two Week High Change | -5.4900002 |
| Fifty Two Week High Change Percent | -0.421659 |
| Fifty Two Week Low | 6.13 |
| Fifty Two Week Low Change | 1.4000001 |
| Fifty Two Week Low Change Percent | 0.228385 |
| Fifty Two Week Range | 6.13 - 13.02 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,273,757,400,000 |
| Float Shares | 65,887,896 |
| Forward Eps | 0.35 |
| Forward P E | 21.514286 |
| Free Cashflow | 178,142,656 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 191 |
| Fullday Change | 0.14000034 |
| Fullday Change Percent | 1.8944566 |
| Fullday Price | 7.53 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.90212 |
| Gross Profits | 417,004,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07609 |
| Held Percent Institutions | 0.57937 |
| Implied Shares Outstanding | 77,944,324 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-02-02 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,553,558,400 |
| Last Split Factor | 1:5 |
| Long Business Summary | CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey. |
| Long Name | CorMedix Inc. |
| Market | us_market |
| Market Cap | 586,920,768 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_79611048 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 186,015,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 598,612,408 |
| Number Of Analyst Opinions | 6 |
| Open | 7.5 |
| Operating Cashflow | 253,936,992 |
| Operating Margins | 0.42097 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Peg Ratio | 5.28 |
| Phone | 908 517 9500 |
| Previous Close | 7.39 |
| Price Hint | 2 |
| Price To Book | 1.2691724 |
| Price To Sales Trailing12 Months | 1.269707 |
| Profit Margins | 0.40492 |
| Quick Ratio | 2.231 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | 0.14000034 |
| Regular Market Change Percent | 1.8944566 |
| Regular Market Day High | 7.61 |
| Regular Market Day Low | 7.49 |
| Regular Market Day Range | 7.49 - 7.61 |
| Regular Market Open | 7.5 |
| Regular Market Previous Close | 7.39 |
| Regular Market Price | 7.53 |
| Regular Market Time | 1,792,074,341 |
| Regular Market Volume | 354,312 |
| Return On Assets | 0.24558 |
| Return On Equity | 0.54932 |
| Revenue Growth | 1.565 |
| Revenue Per Share | 5.91 |
| Sand P52 Week Change | 0.16440773 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 77,944,324 |
| Shares Percent Shares Out | 0.19790001 |
| Shares Short | 15,422,728 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 16,032,112 |
| Short Name | CorMedix Inc. |
| Short Percent Of Float | 0.2005 |
| Short Ratio | 17.97 |
| Source Interval | 15 |
| State | NJ |
| Symbol | CRMD |
| Target High Price | 19.0 |
| Target Low Price | 13.0 |
| Target Mean Price | 15.33333 |
| Target Median Price | 15.0 |
| Total Cash | 256,692,000 |
| Total Cash Per Share | 3.293 |
| Total Debt | 147,455,008 |
| Total Revenue | 462,248,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 2.05 |
| Trailing P E | 3.6731708 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.8184 |
| Two Hundred Day Average Change | -0.2883997 |
| Two Hundred Day Average Change Percent | -0.036887303 |
| Type Disp | Equity |
| Volume | 354,312 |
| Website | https://cormedix.com |
| Zip | 7,054 |